A new ten-point framework for diabetes prevention aims to restore metabolic health across the entire life course, targeting risk factors before disease onset and emphasizing remission. The framework identifies key priorities, including personalized prevention strategies, digital tools, and reducing health inequities.
Weight loss followed by weight regain, known as 'yo-yo dieting,' is not supported by strong scientific evidence. The authors found that benefits of losing weight outweigh the theoretical risks of weight cycling in most cases. Repeated attempts at weight loss can provide meaningful periods of improved metabolic health and quality of life.
A recent study shows that people with newly diagnosed type 2 diabetes have elevated glucagon levels following a meal, closely linked to the fat content of their liver. This finding highlights the importance of the liver and glucagon regulation in metabolism.
A study found that individuals with a high risk of type 2 diabetes do not benefit equally from lifestyle interventions, even after significant weight loss. Rising blood glucose levels and declining insulin secretion were observed in those who failed to show improvements.
Researchers identified a new function of the PICALM protein in skeletal muscle, which responds to physical activity and intermittent fasting. PICALM plays a crucial role in the formation of new muscle fibers and influences cellular processes such as clathrin-mediated endocytosis.
A new study found that almost all people with obesity (BMI ≥ 30 kg/m²) exhibit increased body fat mass and health-related complications. Clinical obesity is associated with a 3-8 times higher risk of cardiovascular disease and type 2 diabetes compared to non-obese individuals.
Researchers developed an AI approach to visualize subtle tissue changes in the pancreas for type 2 diabetes. The study created an extensive data set and trained deep learning models that accurately predicted diabetes status and identified potential biomarkers.
A new study shows that blood flow restriction training (BFRT) effectively strengthens muscle health and metabolism in type 2 diabetes, reducing visceral fat and improving mitochondrial function. BFRT is a low-impact alternative to classic strength training with heavy weights, promoting better insulin action and cardiovascular health.
FAIRification is made possible through a step-by-step approach using the DZD basic data set as an example. The study provides concrete recommendations for the scientific community, facilitating faster comparisons, new findings, and efficient use of existing resources.
Researchers have identified blood-based epigenetic markers that can accurately classify individuals into high-risk prediabetes clusters. These biomarkers reflect different biological signaling pathways and can be used to identify people at high risk of developing type 2 diabetes and its complications early on.
A new study shows that achieving remission of prediabetes significantly reduces the risk of heart attack, heart failure, and premature death. Long-term data from over 2,400 people with prediabetes reveal a 50% lower risk of cardiovascular death and hospitalization for heart failure.
A study found that mitochondria in people with type 2 diabetes and fatty liver disease have impaired ability to utilize ketone bodies for energy production. This defect was greater than the overall decline in mitochondrial function, suggesting a potential new target for improving energy metabolism in diabetes.
A study by the German Diabetes Center found that people with type 2 diabetes and fatty liver disease have impaired mitochondrial ketone body oxidation, reducing their ability to produce energy from ketones. This defect suggests a potential new target for improving energy metabolism in diabetes.
Researchers found that an elevated one-hour blood glucose level after an oral glucose tolerance test can signal a critical metabolic state. Participants with this value responded well to lifestyle interventions, improving insulin sensitivity and beta-cell function, and reducing the risk of type 2 diabetes.
A study found that eating earlier in the day leads to significant changes in fat metabolism, whereas late eating has no measurable effect. The researchers used lipidomics and analyzed gene activity in fat tissue to understand the origin of these effects.
Researchers have found that a one-hour plasma glucose concentration is a more sensitive marker for early detection of impaired glucose tolerance than traditional methods. This biomarker can help identify at-risk individuals and enable targeted prevention strategies.
A new study found that time-restricted eating without calorie restriction does not improve metabolic health in women with overweight or obesity, but shifting the body's internal clocks. The study also revealed that participants who followed a late-eating schedule went to bed and woke up later.
Researchers compared single-cell atlases of pancreas development in humans, pigs, and mice, finding that pigs closely resemble humans in developmental tempo and gene regulation. The study identifies potential alternative sources for regeneration of insulin-producing beta cells, opening up new prospects for regenerative therapies.
A recent study found that patients with prediabetes who normalize their blood sugar levels through healthy lifestyle changes can reduce their risk of type 2 diabetes by up to 71% regardless of weight change, highlighting the importance of blood sugar control over body weight.
A new study found a correlation between sugary drink consumption and depression symptoms in women, suggesting the influence of the intestinal microbiome. The researchers identified an increased number of Eggerthella bacteria in women with high soft drink intake.
Scientists at DZD have identified epigenetic signatures in the blood that indicate how well the brain responds to insulin. The findings suggest a mutual influence between insulin resistance in the brain and metabolic disease, enabling precise classification of individuals with and without insulin resistance.
A large-scale analysis found that biomarkers for chronic inflammation influence the therapeutic success of depressive symptoms in people with diabetes. Type 2 diabetes patients with higher inflammatory markers respond better to behavioral therapy, while those with type 1 diabetes may benefit more from anti-inflammatory treatments.
Research investigates how late eating affects glucose metabolism, finding a link between late meal times and reduced insulin sensitivity. Genetic factors also play a role in determining individual eating behaviors and glucose regulation.
A study found that women exhibit more efficient fat utilization and better glucose and fat handling compared to men after exercise. Regular endurance training led to improvements in metabolic performance and reduced the risk of type 2 diabetes, regardless of sex.
A systematic review of 46 clinical studies with 4,113 participants found that automated insulin delivery (AID) systems improved time in target range and reduced elevated glucose values compared to conventional pump therapy. However, low efficacy was observed during periods with very low glucose levels.
Researchers identified six risk groups for cardiometabolic complications in older people without type 2 diabetes, with a special high-risk group characterized by inflammation and insulin resistance. The study emphasizes the need for precise early detection and prevention strategies.
A study by Helmholtz Munich researchers found that GIPR agonism and antagonism decrease body weight and food intake via different mechanisms. GIPR agonists use GABAergic neurons to exert their effect, while antagonists rely on the GLP-1 receptor signal.
Research identifies six clusters of metabolic dysfunction-associated steatotic liver disease (MASLD) with varying pathophysiology and clinical outcomes. These clusters may enable personalized risk prognosis and treatment through lifestyle modification programs and targeted therapies.
A dynamic signaling network plays a crucial role in regulating insulin action in human muscle cells. The study reveals previously unknown mechanisms that could be used to treat type 2 diabetes, including the stimulation of specific enzymes and protein kinases.
A recent study found that a brief consumption of highly processed foods can alter the brain's sensitivity to insulin in healthy individuals, potentially leading to obesity and type 2 diabetes. This effect was observed even after returning to a balanced diet for one week.
Researchers discovered that PanK4 plays a crucial role in regulating glucose uptake and fatty acid oxidation in skeletal muscles. The protein is activated by physical exercise and has potential as a target for treating metabolic diseases such as type 2 diabetes.
Researchers identified 14 proteins and 2 metabolites associated with prediabetes progression to diabetes, including DCXR and GSTA3. Inflammation and immune system pathways also play a key role in glucose homeostasis.
A study comparing hybrid closed-loop and open-loop systems in young people with type 1 diabetes found that hybrid closed-loop systems offered improved long-term blood sugar values, a lower risk of hypoglycemic coma, but a higher rate of diabetic ketoacidosis. The results suggest that hybrid closed-loop therapies may be beneficial for i...
Researchers have identified three major pathomechanisms of MASLD: hepatic genetic component, metabolic de novo lipogenesis, and adipose tissue dysfunction. These subtypes have distinct risk factors for cardiovascular disease and type 2 diabetes. Novel pharmacological approaches may facilitate targeted therapies for each subtype.
A clinical study found increased permeability of the small intestine and inflammation in the gut, linked to higher body weight and insulin resistance. The researchers emphasize the need for further investigations into carrageenan's effects on human health.
The study found that both axolotls and fruit flies exhibit distinct lipid adjustments during regeneration, with males increasing circulating lipids and females storing lipids in the liver. Insulin signaling pathways play a crucial role in adapting lipid metabolism to meet the needs of cell proliferation.
New studies using magnetic resonance imaging show that GLP-1 RA treatments cause a normal, adaptive process in skeletal muscle changes. Weight loss leads to improved insulin sensitivity and reduced fat in muscles, improving quality. Better muscle quality is associated with lower risk of strength and function loss.
Research reveals the structural features of beta cell primary cilia, including microtubule organization and interactions with neighboring cells. The findings suggest that primary cilia play a crucial role in signal transmission and networking of beta cells with other islet cells, potentially linking to type 2 diabetes pathogenesis.
A high-fat diet can promote overweight and increase diabetes risk, but fat alone does not change the brain's hypothalamus. Other macronutrients like sugar may have more profound effects on AgRP neurons.
Scientists identify PICALM as a key player in regulating glucose homeostasis and insulin signaling in adipocytes. Reduced expression of PICALM improves insulin sensitivity and glucose transport, holding promise for new therapeutic approaches for type 2 diabetes and obesity.
Researchers found distinct molecular responses in skeletal muscle following bariatric surgery between obese individuals and those with additional T2D. Obesity individuals showed improvements in metabolic health, while T2D participants had limited changes.
Experts advocate for incorporating normalization of blood sugar regulation into diabetes prevention strategies. Studies show that weight loss-induced prediabetes remission can significantly reduce the risk of developing type 2 diabetes, especially when combined with lifestyle changes.
A study published in Science Advances reveals a special group of 'first responder' cells in the pancreas that trigger blood sugar response. These cells respond to glucose quicker than others, initiating the response and regulating the activity of other beta cells.
Severe obesity can alter metabolism and psyche, leading to impulsive behavior and a willingness to take risks. A study found that massive weight loss improved glucose metabolism and mood, allowing for more metabolically driven decision-making.
Research suggests that metabolically healthy obese individuals have a significantly lower risk of cardiovascular disease and death compared to those with metabolic unhealthy obesity. Fat distribution plays a crucial role in defining metabolic health, according to a recent review article.
A recent study found that for every same increase of BMI, fat mass and type 2 diabetes risk are increased in taller people. The authors hypothesize that the cardiometabolic risk of a higher BMI may be underestimated in taller grown populations worldwide.
Researchers found that people who achieved weight loss and prediabetes remission had a 76% lower risk of developing type 2 diabetes compared to those who only lost weight. This suggests that normalization of blood sugar levels should be included as a therapeutic goal in guidelines to improve diabetes prevention.
Researchers found that Kallistatin expression increases after weight loss in individuals with overweight and obesity. Additionally, human Kallistatin improves hepatic insulin sensitivity in diet-induced obese mice. The study suggests that Kallistatin may be an interesting therapeutic target for people with obesity and type 2 diabetes.
Researchers developed an algorithm to stratify people with type 2 diabetes using routine data, revealing metabolic diversity and insulin sensitivity variability. The study's findings have the potential to change the way we understand and treat type 2 diabetes.
Researchers used the Gompertz model to predict mortality rates in people with type 2 diabetes, achieving values of over 97% accuracy in their predictions. The study found that mortality rates increase exponentially with age and are higher in females due to lower life expectancy.